Worth Seeing!
TEDx Talk by Raymond Moses: Empowering the Billion, Unleashing the Investing Potential Watch Now Watch Now
mw4me logo
Talk to Us | Subscribe | Advisory Services

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 72987.03
117.58 (-0.16%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on May-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
61
Aster DM Healthcare Ltd.
17,371
(Small Cap)
350.30
(0.73%)
53.6
3.78
12.17
15.37
Q V PT
62
Kopran Ltd.
1,195
(Small Cap)
249.35
(0.63%)
48.08
2.98
12.18
217.28
Q V+ PT
63
Krishna Institute of Medical Sciences Ltd
15,616
(Small Cap)
1,942.75
(-0.44%)
59.64
8.59
12.50
0.00
Q V PT
64
Alembic Pharmaceuticals Ltd.
18,948
(Small Cap)
969.35
(0.56%)
30.77
3.93
12.54
23.14
Q V PT
65
Ipca Laboratories Ltd.
32,669
(Mid Cap)
1,274.50
(-1.03%)
59.35
5.15
12.58
17.37
Q V+ PT
66
Shalby Ltd.
2,876
(Small Cap)
273.15
(2.59%)
28.86
2.76
13.24
14.33
Q V PT
67
Jagsonpal Pharmaceuticals Ltd.
859
(Small Cap)
329.30
(1.35%)
35.04
4.8
13.35
0.00
Q V+ PT
68
Hester Biosciences Ltd.
1,487
(Small Cap)
1,747.70
(-0.04%)
54.76
4.76
13.51
0.65
Q V+ PT
69
Eris Lifesciences Ltd.
11,906
(Small Cap)
880
(0.55%)
30.81
4.74
14.52
6.67
Q V PT
70
Narayana Hrudayalaya Ltd.
25,530
(Small Cap)
1,255
(0.46%)
33.08
9.49
14.68
62.83
Q V+ PT
71
Divis Laboratories Ltd.
1,03,416
(Large Cap)
3,886
(-0.25%)
74.78
7.93
14.82
15.00
Q V PT
72
Bliss GVS Pharma Ltd.
1,151
(Small Cap)
110.10
(0.18%)
22.72
1.16
14.97
1.73
Q V+ PT
73
Mankind Pharma Ltd.
90,041
(Large Cap)
2,195
(-2.33%)
54.56
9.83
15.71
13.53
Q V PT
74
Poly Medicure Ltd.
16,116
(Small Cap)
1,671.70
(-0.45%)
67.52
11.62
16.00
20.25
Q V+ PT
75
Supriya Lifescience Ltd.
3,080
(Small Cap)
379
(-0.98%)
25.58
3.93
16.71
67.00
Q V+ PT
76
Aarti Drugs Ltd.
4,359
(Small Cap)
480.20
(1.29%)
25.43
3.4
16.91
15.52
Q V PT
77
KMC Speciality Hospitals (India) Ltd.
1,460
(Small Cap)
88.53
(-1.08%)
N/A
N/A
17.12
31.95
Q V+ PT
78
Marksans Pharma Ltd.
7,185
(Small Cap)
164.50
(3.75%)
60.59
6.04
17.33
59.01
Q V PT
79
Gland Pharma Ltd.
29,056
(Mid Cap)
1,773.90
(0.56%)
36.27
3.35
17.42
19.02
Q V PT
80
Syngene International Ltd.
26,932
(Mid Cap)
672.05
(0.45%)
57.73
6.42
17.55
15.81
Q V+ PT
81
Neuland Laboratories Ltd.
7,911
(Small Cap)
6,255
(1.44%)
26.41
6.2
17.70
56.85
Q V+ PT
82
Gufic Biosciences Ltd.
3,271
(Small Cap)
321.80
(-1.35%)
38.85
6.38
17.71
34.15
Q V PT
83
JB Chemicals & Pharmaceuticals Ltd.
27,799
(Small Cap)
1,804.10
(0.72%)
54.92
9.89
18.11
31.92
Q V+ PT
84
Bajaj Healthcare Ltd.
842
(Small Cap)
305
(-0.03%)
39.59
2.62
18.39
25.96
Q V PT
85
Morepen Laboratories Ltd.
2,371
(Small Cap)
46.60
(0.47%)
29.18
2.78
19.01
9.18
Q V PT
86
Granules India Ltd.
9,690
(Small Cap)
396.50
(-0.83%)
20.88
3.22
19.01
31.51
Q V PT
87
NGL Fine-Chem Ltd.
1,467
(Small Cap)
2,334.80
(-1.65%)
40.51
5.82
19.33
11.86
Q V+ PT
88
Jupiter Life Line Hospitals Ltd.
8,213
(Small Cap)
1,250
(-0.21%)
54.05
6.6
19.71
26.72
Q V PT
89
Max Healthcare Institute Ltd.
79,255
(Mid Cap)
830.70
(1.87%)
74.98
9.74
21.42
0.00
Q V+ PT
90
Caplin Point Laboratories Ltd.
10,093
(Small Cap)
1,351.55
(1.70%)
23.06
4.6
22.13
21.09
Q V PT
3

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Strides Pharma Scien
875.355.64%
Vijaya Diagnostic
802.605.52%
Sanofi India
8,385.154.97%
Jubilant Pharmova
717.204.29%
Marksans Pharma
164.503.75%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Aarti Pharmalabs
586.70-5.62%
Dishman Carbogen Amc
193.95-4.39%
Solara Active Pharma
486.40-3.38%
Themis Medicare
202.55-2.90%
IOL Chem & Pharma
366.25-2.76%
View More

News about Top Pharma Companies in India

Granules India reports 8% rise in Q4 consolidated net profit

Total consolidated income of the company decreased by 1.77% at Rs 1,177.65 crore for Q4FY24
15 May, 2024

Granules India informs about outcome of board meeting

Granules India has informed that the Board of Directors at their meeting dated 15th May 2024 has approved the audited financial results (Standalone & Consolidated) for the fourth quarter and financial year ended on March 31, 2024 prepared under Indian Accounting Standards (Ind - AS) along with the Auditor’s report thereon. Recommended to the members, a final dividend of Rs. 1.50/- per share of the face value of Re. 1/- each for the financial year 2023-24 representing 150% of the paid-up equity share capital of the Company. The record date for payment of the final dividend shall be July 30, 2024. Re-appointed Harsha Chigurupati (DIN:01606477) as a Whole-time Director of the Company for a further term of 5(Five) years since his current term is concluding on August 28, 2024. His re-appointment is subject to the approval of the members. Re-appointed Dr. Krishna Prasad Chigurupati (DIN: 00020180) as a Chairman & Managing Director of the Company for a further term of 5(Five) years since his current term is concluding on August 31, 2024. His re-appointment is subject to the approval of the members. Fixed the date of the 33rd Annual General Meeting of the members of the Company on Tuesday, August 06, 2024. Fixed the date of Book closure from July 31, 2024 to August 06, 2024 for the purpose of the 33rd Annual General Meeting of the Company. The meeting of the Board of Directors of the Company commenced at 09.00 AM and concluded at 12.10 PM.

The above information is a part of company’s filings submitted to BSE.
15 May, 2024

Granules India informs about audited financial results

Granules India has informed that the Board of Directors at their meeting has approved the audited financial results (Standalone & Consolidated) for the fourth quarter and financial year ended on March 31, 2024 prepared under Indian Accounting Standards (Ind - AS) along with the Auditor’s report thereon. Pursuant to regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), they are enclosing the audited financial results (Standalone and Consolidated) of the Company for the fourth quarter and financial year ended on March 31, 2024. They hereby confirmed and declared that the statutory auditors of the Company, S R Batliboi & Associates LLP, Chartered Accountants registered vide Firm Registration No. 101049W/E300004 have in their report issued an unmodified opinion on the standalone and consolidated financial results for the financial year ended on March 31, 2024. They also enclosed a copy of the report of the Company’s statutory auditors, as required under Regulation 33 of the Listing Regulations. The meeting of the Board of Directors of the Company commenced at 09.00 AM and concluded at 12.10 PM.

The above information is a part of company’s filings submitted to BSE.
15 May, 2024

Jupiter Life Line Hospitals informs about audio link of conference call

Pursuant to Regulation 30 and Regulation 46(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jupiter Life Line Hospitals has informed that the Audio Link of the Conference Call held today Monday, May 13, 2024 at 10:00 am IST for the quarter and financial year ended March 31, 2024 has been made available on the website of the Company.

The above information is a part of company’s filings submitted to BSE.

13 May, 2024

Jupiter Life Line Hospitals inches up on getting nod for addition of beds in existing Indore Hospital, Pune Hospital

The Board of Directors of the company at its meeting held on May 10, 2024 has approved the same
13 May, 2024

Jupiter Life Line Hospitals gets nod for addition of beds in existing Indore Hospital, Pune Hospital

The Board of Directors of the company at its meeting held on May 10, 2024 has approved the same
11 May, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Sastasundar Ventures Ltd. 913 Crore
2 Suven Life Sciences Ltd. 2,187 Crore
3 Jubilant Pharmova Ltd. 10,954 Crore
4 Panacea Biotec Ltd. 820 Crore
5 Novartis India Ltd. 2,594 Crore
6 Wockhardt Ltd. 8,423 Crore
7 Biocon Ltd. 37,309 Crore
8 Apollo Hospitals Enterprise Ltd. 84,244 Crore
9 Innova Captab Ltd. 2,689 Crore
10 Aarti Pharmalabs Ltd. 5,634 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,385 18,397 33.48 16.97 21.44 51.69
Abbott India Ltd. (M) Very Good 26,356 56,915 47.38 15.39 32.20 31.69
Laurus Labs Ltd. (S) Very Good 435.4 23,359 145.5 5.68 32.00 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 5,872 97,939 17.56 3.47 11.09 20.88
Torrent Pharmaceuticals Ltd. (L) Very Good 2,651 89,016 59.58 12.45 28.59 20.23

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Lupin Ltd. (M) Somewhat Good 1,638 74,572 111.5
Zydus Lifesciences Ltd. (L) Very Good 997.5 99,089 91.81
Aurobindo Pharma Ltd. (M) Very Good 1,158 68,347 91.19
Ipca Laboratories Ltd. (M) Very Good 1,275 32,669 85.37
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,804 27,799 75.26
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 435.4 23,359 145.5 5.68 32.00 24.05
Granules India Ltd. (S) Somewhat Good 396.5 9,690 20.88 3.22 12.69 19.01
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,804 27,799 54.92 9.89 32.45 18.11
Gland Pharma Ltd. (M) Very Good 1,774 29,056 36.27 3.35 20.65 17.42
Mankind Pharma Ltd. (L) Very Good 2,195 90,041 54.56 9.83 37.68 15.71

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 435.4 23,359 145.5 5.68 32.00 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 5,872 97,939 17.56 3.47 11.09 36.08
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,804 27,799 54.92 9.89 32.45 31.92
Biocon Ltd. (M) Somewhat Good 311.6 37,309 19.47 3.43 100.4 31.80
Granules India Ltd. (S) Somewhat Good 396.5 9,690 20.88 3.22 12.69 31.51
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
SEBI Registered: Investment Adviser - INA000013323
Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.